Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders
17 September 2022 - 6:30AM
Intercure Ltd. (the “Company”) announces today the results of the
Annual and Special General Meeting of shareholders of the Company,
held on Thursday, September 15, 2022, in Bnei Brak, Israel (the
“Meeting”). At the Meeting, all of the proposals set forth in the
Company’s management information circular dated August 10, 2022
(the “Circular”) were approved by the required majority of the
shareholders.
Each of the four nominees listed in the
management information circular prepared in connection with the
Meeting were elected as directors of the Company. The Company
received proxies and votes at the Meeting as set out below:
Nominee |
Votes For |
% of VotesFor |
VotesWithheld |
% of VotesWithheld |
Ehud Barak |
17,819,294 |
99.76% |
225 |
0.001% |
Alexander Rabinovitch |
17,144,620 |
95.99% |
359 |
0.001% |
David Salton |
17,818,147 |
99.74% |
359 |
0.001% |
Alon Granot |
17,818,039 |
99.75% |
359 |
0.001% |
Ordinary resolutions approving the Company’s new
Israeli Option Plan, the extension of the exercise period of stock
options granted to the Chairman of the Board, the grant of 250,170
stock options to certain employees and service providers on August
31, 2021, the grant of 460,000 stock options to the Chief Executive
Officer of the Company on June 21, 2022 and the compensation
increase for the Chief Executive Officer of the Company were also
each passed by a majority of the votes represented at the Meeting,
as well as the majority of the disinterested votes represented at
the Meeting.
Details of the voting results on all matters
considered at the Meeting are available in the Company’s report of
voting results, which is available under the Company’s profile on
SEDAR at www.sedar.com.
About
InterCure (dba
Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX:
INCR.U) (TASE: INCR) is the leading, profitable, and fastest
growing cannabis company outside of North America. Canndoc, a
wholly owned subsidiary of InterCure, is Israel’s largest licensed
cannabis producer and one of the first to offer Good Manufacturing
Practices (GMP) certified and pharmaceutical-grade medical cannabis
products. InterCure leverages its market leading distribution
network, best in class international partnerships and a high-margin
vertically integrated "seed-to-sale" model to lead the fastest
growing cannabis global market outside of North America.
For further information, please
contact:
Amos Cohen, Chief Financial Officer
Tel: +972-58-666-8686
Intercure (TSX:INCR.U)
Historical Stock Chart
From May 2024 to Jul 2024
Intercure (TSX:INCR.U)
Historical Stock Chart
From Jul 2023 to Jul 2024